ORGENESIS INC(NASDAQ:ORGS) stock News

ORGS Latest News, Press Relases and Analysis

All

Press Releases

7 months ago - By: ACCESS Newswire

Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies

8 months ago - By: ACCESS Newswire

Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings

a year ago - By: Orgenesis Inc.

Orgenesis Provides Third Quarter 2024 Business Update

a year ago - By: Benzinga - Mentions: CYCC CHRO MTEM CMAX ...

12 Health Care Stocks Moving In Friday's Intraday Session

a year ago - By: Benzinga - Mentions: NFLX DRUG NUZE SOBR ...

Dow Falls Over 100 Points; Netflix Posts Upbeat Results

a year ago - By: Orgenesis Inc.

Orgenesis Announces Reverse Stock Split

a year ago - By: BusinessInsider

ORGS Stock Earnings: Orgenesis Reported Results for Q2 2024

a year ago - By: Orgenesis Inc.

Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia

a year ago - By: Orgenesis Inc.

Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally

a year ago - By: InvestorPlace

ORGS Stock Earnings: Orgenesis Reported Results for Q2 2024

a year ago - By: BusinessInsider

ORGS Stock Earnings: Orgenesis Reported Results for Q4 2023

a year ago - By: Orgenesis Inc.

Orgenesis Provides Second Quarter 2024 Business Update

a year ago - By: InvestorPlace

ORGS Stock Earnings: Orgenesis Reported Results for Q4 2023

a year ago - By: BusinessInsider

ORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024

a year ago - By: InvestorPlace

ORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024

a year ago - By: Orgenesis Inc.

Orgenesis Provides Business Update for the First Quarter of 2024

1 years ago - By: Orgenesis Inc.

Orgenesis Provides Year End Business Update

1 years ago - By: Orgenesis Inc.

Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility

2 years ago - By: InvestorPlace - Mentions: HWH ZCMD HUBC BROG ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

2 years ago - By: Orgenesis Inc.

Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference

2 years ago - By: Orgenesis Inc.

Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes

2 years ago - By: Orgenesis Inc.

Orgenesis Inc. Announces $2.3 Million Private Placement

2 years ago - By: Orgenesis Inc.

ORGENESIS INC (ORGS) Stock News

ORGS Latest News, Press Relases and Analysis

Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies

Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings

Orgenesis Provides Third Quarter 2024 Business Update

12 Health Care Stocks Moving In Friday's Intraday Session

Dow Falls Over 100 Points; Netflix Posts Upbeat Results

Orgenesis Announces Reverse Stock Split

ORGS Stock Earnings: Orgenesis Reported Results for Q2 2024

Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia

Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally

ORGS Stock Earnings: Orgenesis Reported Results for Q2 2024

ORGS Stock Earnings: Orgenesis Reported Results for Q4 2023

Orgenesis Provides Second Quarter 2024 Business Update

ORGS Stock Earnings: Orgenesis Reported Results for Q4 2023

ORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024

ORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024

Orgenesis Provides Business Update for the First Quarter of 2024

Orgenesis Provides Year End Business Update

Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference

Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes

Orgenesis Inc. Announces $2.3 Million Private Placement

Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing